David K. Glasgow is the acting director for the Bioresearch Monitoring Program within the Office of Regulatory Affairs (ORA) at the Food and Drug Administration (FDA). As the acting program director, Mr. Glasgow is responsible for working with counterparts from each of FDA’s six product centers in establishing a new, stand-alone Bioresearch Monitoring Program that includes all commodity areas. This work includes establishing a foundational training and development program, consistent and standardized processes across the program, and developing and implementing a complete governance system for the program. Mr. Glasgow’s permanent position is director, Division of Food and Feed Program Operations and Inspections. He has also been the director of the Investigations Branch in the Dallas District, a supervisory investigator in the Kansas City District, a bioresearch monitoring specialist in the Baltimore District, an investigator in the Denver District, a consumer safety inspector in the Los Angeles District. He began his career with FDA in 1987 as a clerk-typist in the Los Angeles District.